United States · FDA National Drug Code directory
Vabrinty
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85043-025_27e114f0-8c42-47c3-bcb8-0da93eb9a5fb
- Product NDC
- 85043-025
- Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- Leuprolide acetate
- Labeler
- URONOVA PHARMACEUTICALS, INC.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20250804
- Source listing expiry
- 20271231
Source-listed ingredients
- LEUPROLIDE ACETATE — 22.5 mg/.375mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (85043-025-02) / .375 mL in 1 SYRINGE · 85043-025-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →